Related Experiment Video
Updated: Dec 13, 2025
05:44
Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
Published on: June 10, 2025
664
Current Insights in Cutaneous Lupus Erythematosus Immunopathogenesis
Colton J Garelli1, Maggi Ahmed Refat1, Padma P Nanaware2
1Department of Dermatology, University of Massachusetts Medical School, Worcester, MA, United States.
Frontiers in Immunology
|July 28, 2020
Summary
Cutaneous Lupus Erythematosus (CLE) is a diverse autoimmune skin condition. This review covers CLE
Area of Science:
- Immunodermatology
- Autoimmune Diseases
- Cutaneous Lupus Erythematosus
Background:
- Cutaneous Lupus Erythematosus (CLE) presents diverse clinical manifestations.
- Histologically, CLE features interface dermatitis and autoantibody deposition at the dermal-epidermal junction.
- Genetic and environmental factors trigger immune cell infiltration in CLE lesions.
Purpose of the Study:
- To review the clinical spectrum of Cutaneous Lupus Erythematosus.
- To elucidate the immunopathogenesis of CLE.
- To discuss emerging therapeutic strategies for CLE.
Main Methods:
- Literature review of clinical features.
- Analysis of immunopathogenic mechanisms.
- Survey of novel treatment approaches.
Main Results:
- CLE exhibits significant clinical heterogeneity.
- Immune cell infiltration (T cells, B cells, neutrophils, APCs, NK cells) is a hallmark of CLE pathogenesis.
- Current research focuses on targeted therapies.
Conclusions:
- Understanding CLE's clinical diversity and immunopathogenesis is crucial.
- Novel treatments offer promise for managing CLE.
- Further research is needed to refine therapeutic strategies.
